Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Optical Immunosensors Improve POC Diagnostics

By LabMedica International staff writers
Posted on 12 Feb 2009
Optical immunosensors are precise, fast, easy-to-use systems for point-of-care diagnostics in hospitals, physicians' practices, or in homecare.

Scientists have been working on the development of selective monoclonal antibodies (mAbs) for certain target structures and for use in immunosensors for some time. More...
They have now succeeded in developing mAbs for procalcitonin (PCT), a specific marker for microbial infections and sepsis. Determination of PCT concentrations in serum is of significance, both for the early diagnosis of microbial infections and for controlling antibiotic treatment.

Using surface plasmon resonance (SPR) technology, biomolecular interactions between analytes in solution and antibodies immobilized on the surface of the sensor can be detected quickly, with high sensitivity, and without the otherwise required labeling of reaction partners.

SPR-based immunosensors are of interest for the detection of ligands in biomedical applications, in food, or in the environment. Dr. M. F. Gouzy, from the Institute of Ecological Chemistry, Helmholtz Center Munich (Munich, Germany), and colleagues have succeeded in developing a reusable SPR-based immunosensor, which is described in the February 2009 issue of the journal Biosensors and Bioelectronics.

Newly developed procalcitonin (PCT) antibodies from the rat were used successfully in the enzyme-linked immunosorbant assay (ELISA) in testing human serum for PCT. Some of these mAbs were marked with fluorescent dye and are presently being integrated by scientific groups in Germany and Italy into new optical immunosensors.

Related Links:
Helmholtz Center



New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
Pipette Calibration System
Artel PCS®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Researchers identified blood-based genomic signatures characteristic of inflammatory breast cancer (photo courtesy of Shutterstock)

Liquid Biopsy Biomarkers Distinguish Inflammatory Breast Cancer and Support Monitoring

Inflammatory breast cancer is among the most aggressive forms of breast malignancy and remains challenging to diagnose and monitor. Obtaining tumor tissue can be difficult, and standard genome and RNA... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.